Dabotulinumtoixna-ianm-(DAXXIFY)- (Sep 2022)- to treat moderate to severe glabellar lines associated with corrugation
Drug Name:Dabotulinumtoixna-ianm-(DAXXIFY)- (Sep 2022)- to treat moderate to severe glabellar lines associated with corrugation
List Of Brands:
Indication Type Description: